Nuvectra Corp (NASDAQ:NVTR) Director Joseph A. Miller purchased 25,000 shares of Nuvectra Corp stock in a transaction that occurred on Thursday, March 16th. The shares were bought at an average price of $6.11 per share, for a total transaction of $152,750.00. Following the completion of the transaction, the director now owns 35,743 shares in the company, valued at $218,389.73. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.
Shares of Nuvectra Corp (NASDAQ:NVTR) traded down 0.94% during midday trading on Monday, hitting $6.29. The stock had a trading volume of 38,700 shares. The company’s 50 day moving average is $7.29 and its 200 day moving average is $6.30. Nuvectra Corp has a 52-week low of $4.02 and a 52-week high of $9.95. The company’s market cap is $65.02 million.
Nuvectra Corp (NASDAQ:NVTR) last announced its quarterly earnings data on Tuesday, March 7th. The company reported ($1.27) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.89) by $0.38. Nuvectra Corp had a negative net margin of 320.73% and a negative return on equity of 33.89%. The business earned $4.20 million during the quarter, compared to analysts’ expectations of $3.97 million. During the same quarter in the previous year, the firm earned ($0.55) earnings per share. Nuvectra Corp’s revenue was up 223.1% on a year-over-year basis. On average, analysts anticipate that Nuvectra Corp will post ($4.36) earnings per share for the current year.
Your IP Address:
Several equities analysts recently issued reports on the company. B. Riley restated a “buy” rating and set a $12.00 price target on shares of Nuvectra Corp in a research report on Wednesday, March 8th. Zacks Investment Research lowered Nuvectra Corp from a “buy” rating to a “hold” rating in a research report on Wednesday, January 11th.
Several large investors have recently bought and sold shares of NVTR. Tower Research Capital LLC TRC increased its stake in Nuvectra Corp by 538.8% in the third quarter. Tower Research Capital LLC TRC now owns 14,572 shares of the company’s stock worth $101,000 after buying an additional 12,291 shares in the last quarter. FNY Managed Accounts LLC purchased a new stake in Nuvectra Corp during the third quarter worth approximately $389,000. Palisade Capital Management LLC NJ purchased a new stake in Nuvectra Corp during the third quarter worth approximately $453,000. FNY Partners Fund LP purchased a new stake in Nuvectra Corp during the fourth quarter worth approximately $429,000. Finally, Renaissance Technologies LLC increased its stake in Nuvectra Corp by 77.7% in the fourth quarter. Renaissance Technologies LLC now owns 86,200 shares of the company’s stock worth $434,000 after buying an additional 37,700 shares in the last quarter. Institutional investors own 61.35% of the company’s stock.
Nuvectra Corp Company Profile
Nuvectra Corporation is a neurostimulation company that focuses on helping physicians to improve the lives of people with chronic neurological conditions. The Company’s Algovita Spinal Cord Stimulation (SCS) System (Algovita) is the Company’s commercial offering and is Conformite Europeene (CE) marked and the United States Food and Drug Administration (FDA) approved for the treatment of chronic pain of the trunk and/or limbs.
This story was originally published by WKRB News (http://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://www.wkrb13.com/markets/2024212/nuvectra-corp-nvtr-director-acquires-152750-00-in-stock.html
Receive News & Ratings for Nuvectra Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuvectra Corp and related companies with MarketBeat.com's FREE daily email newsletter.